SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

Raymond James Reiterates Outperform on Tenet Healthcare, Lowers Price Target to $48

Raymond James reiterates Tenet Healthcare (NYSE:THC) with a Outperform and lowers the price target from $50 to $48.

Benzinga · -

Raymond James reiterates Tenet Healthcare (NYSE:THC) with a Outperform and lowers the price target from $50 to $48.